Seegene, Inc. (KOSDAQ:096530)

Market Cap	1.10T
Revenue (ttm)	414.25B
Net Income (ttm)	-20.34B
Shares Out	46.04M
EPS (ttm)	-441.00
PE Ratio	n/a
Forward PE	26.32
Dividend	800.00 (3.34%)
Ex-Dividend Date	Mar 28, 2025

Volume	217,755
Average Volume	437,768
Open	25,000
Previous Close	25,100
Day's Range	23,950 - 25,150
52-Week Range	19,500 - 35,950
Beta	-1.16
RSI	45.02
Earnings Date	May 15, 2025

About Seegene

Seegene, Inc. manufactures and sells molecular diagnostics products worldwide. It offers IVD products comprising respiratory disease detection products for respiratory infections; gastrointestinal disease detection products for gastrointestinal tract infections; human papillomavirus detection products; sexually transmitted infections causative pathogens detection products; tuberculosis detection products; drug resistance products; Magicplex sepsis real-time test for the detection and identification of sepsis causing pathogens; and meningitis de...

• Industry: Medical - Specialties
• Sector: Healthcare
• Founded: 2000
• Employees: 63
• Stock Exchange: KOSDAQ
• Ticker Symbol: 096530

Financial Performance

In 2023, Seegene's revenue was 367.38 billion, a decrease of -56.96% compared to the previous year's 853.56 billion. Earnings were 669.01 million, a decrease of -99.63%.